SEC Filing Update: #PTGX Protagonist Therapeutics, Inc. : $141.12

Sector: Healthcare | YTD: 🔼+ 61.83% The SEC disclosed Today (27-OCT-2026) that BLACKROCK INC has DECREASED #PTGX Shares by -4.60% 🔴 * Previous Holdings: 10.31M Shares * Current Holdings: 9.83M Shares * Decrease -473.69K * Decreased (%)-4.60% * Ownership: 15.2% https://www.thinksabio.com/reports/isr/PTGX The quarterly average prices of #PTGX: Q2 2025: $48.00 Q3 2025: $56.82 Q4 2025: $81.75 Q1 2026: $88.54 Q2 2026: $104.46 📈 Stay ahead of institutional buy/sell moves — Sign up free at ThinkSabio: Sign Up Free →